Compare · CNMD vs CV
CNMD vs CV
Side-by-side comparison of CONMED Corporation (CNMD) and CapsoVision Inc. (CV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and CV operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD is the larger of the two at $1.16B, about 3.8x CV ($302.5M).
- Over the past year, CNMD is down 24.5% and CV is up 51.0% - CV leads by 75.5 points.
- Both names hit the wire about 2 times in the past 4 weeks.
- CNMD has more recent analyst coverage (14 ratings vs 2 for CV).
- Company
- CONMED Corporation
- CapsoVision Inc.
- Price
- $38.41+2.52%
- $6.05+5.03%
- Market cap
- $1.16B
- $302.5M
- 1M return
- +3.74%
- -27.49%
- 1Y return
- -24.48%
- +51.00%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- 2025
- News (4w)
- 2
- 2
- Recent ratings
- 14
- 2
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Latest CNMD
- SEC Form DEFA14A filed by CONMED Corporation
- SEC Form DEF 14A filed by CONMED Corporation
- SEC Form 4 filed by Beyer Pat
- CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- Amendment: SEC Form 4 filed by Lalomia Brent
- Amendment: SEC Form 4 filed by Schabacker Matthew
- Amendment: SEC Form 4 filed by Foust Hollie K
- Amendment: SEC Form 4 filed by Ferrell John D.
- Amendment: SEC Form 4 filed by Shagory Peter K
Latest CV
- SEC Form EFFECT filed by CapsoVision Inc.
- SEC Form S-1 filed by CapsoVision Inc.
- SEC Form 3 filed by new insider Shen Ching Hang
- SEC Form 3 filed by new insider Harari Eliyahou Et Al
- SEC Form 10-K filed by CapsoVision Inc.
- CapsoVision Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
- SEC Form 4 filed by Tsai Chen Lung
- SEC Form 4 filed by Kuo Hui Ying
- SEC Form 4 filed by King Wen-Herng Henry